View Document Preview and Link Document Date: 2013-03-18 13:37:31 Open Document File Size: 106,21 KB Share Result on Facebook
City Ann Arbor / Malvern / Tokyo / / Company Bayer / Cepheid / B9 Bionor / B12 Astellas / Thomson Reuters / BioCentury / BERNSTEIN / Promedior Inc. / B9 BioDelivery / Genzyme Corp. / B9 Biogen Idec / tables/A19 Company / B20 BioAlliance / Dendreon / B5 Bavarian Nordic / Arresto B16 Arrowhead / B20 BioSpecifics / B8 Bionovo / B17 AstraZeneca / B9 BioMarin / B9 Baxter / B17 Biovail / Celldex / / Currency USD / EUR / / Event FDA Phase / Person Communication and Meetings / Conference Call / M&A / / Facility Baylor College of Medi / Rice University / / IndustryTerm pharmaceutical sales last year / poredundant systems / organ systems / wound site / dundant systems / / MedicalCondition glaucoma / fibrotic disorders / liver Senior Writer fibrosis / cardiac dysfunction / obesity / asthma / significantly attenuated disease / ventricular dysfunction / cardiomyopathy / induced allergic airway disease / scars / idiopathic pulmonary fibrosis / rare disease / Allergy / inflammatory component / diseases / severe asthma / post-surgical scarring glaucoma / fibrosis / / OperatingSystem OSE / / Organization Rice University / Houston / Rice University / Baylor College of Medi / Baylor College of Medicine / Houston / National Academy of Science / FDA / Michigan Medical School / / Person Zenobia Therapeutics / Karen Bernstein / Dominick Colangelo / Michael Flanagan / Aaron Bouchie / / / Position renal and liver Senior Writer / CEO / / Product PMR-151 / PRM-151 / / ProvinceOrState Texas / Michigan / Pennsylvania / / SportsEvent China SEED Tour / / Technology Alphabody technology / / SocialTag 
WEEK OF SEPTEMBER 6, 2010 BioCentury THE BERNSTEIN REPORT ON BIOBUSINESS Volume 18 Number 39 Page A1 of 21